Dynamic prostatic and laser-ablated lesion volume change after transperineal laser ablation in canine: preliminary observation and its clinical significance

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Resnick MJ, Koyama T, Fan KH, et al. Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013;368(5):436–445.
   PubMed Web of Science ®Google Scholar
• Sanchez-Salas R, de la Rosette J, Polascik TJ, et al. Focal therapy for prostate cancer: a more vehement view of the approach could translate into real benefits for our patients. Eur Urol. 2018;74(5):537–539.
   PubMed Web of Science ®Google Scholar
• Ghai S, Perlis N, Lindner U, et al. Magnetic resonance guided focused high frequency ultrasound ablation for focal therapy in prostate cancer - phase 1 trial. Eur Radiol. 2018;28(10):4281–4287.
   PubMed Web of Science ®Google Scholar
• Guo Z, Si T, Yang X, et al. Oncological outcomes of cryosurgery as primary treatment in T3 prostate cancer: experience of a single centre. BJU Int. 2015;116(1):79–84.
   PubMed Web of Science ®Google Scholar
• Azzouzi AR, Vincendeau S, Barret E, et al. Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. Lancet Oncol. 2017;18(2):181–191.
   PubMed Web of Science ®Google Scholar
• Natarajan S, Raman S, Priester AM, et al. Focal laser ablation of prostate cancer: phase I clinical trial. J Urol. 2016;196(1):68–75.
   PubMed Web of Science ®Google Scholar
• Shariat SF, Raptidis G, Masatoschi M, et al. Pilot study of radiofrequency interstitial tumor ablation (RITA) for the treatment of radio-recurrent prostate cancer. Prostate. 2005;65(3):260–267.
   PubMed Web of Science ®Google Scholar
• Strohmaier WL, Bichler KH, Bocking A, et al. Histological effects of local microwave hyperthermia in prostatic cancer. Int J Hyperthermia. 1991;7(1):27–33.
   PubMed Web of Science ®Google Scholar
• Ben-Tuvim N. Laser-light amplification by stimulated emission of radiation. Harefuah. 1963;65:191–194.
   PubMedGoogle Scholar
• Izzo F. Other thermal ablation techniques: microwave and interstitial laser ablation of liver tumors. Ann Surg Oncol. 2003;10(5):491–497.
   PubMed Web of Science ®Google Scholar
• Lindner U, Trachtenberg J, Lawrentschuk N. Focal therapy in prostate cancer: modalities, findings and future considerations. Nat Rev Urol. 2010;7(10):562–571.
   PubMed Web of Science ®Google Scholar
• Eggener SE, Yousuf A, Watson S, et al. Phase II evaluation of magnetic resonance imaging guided focal laser ablation of prostate cancer. J Urol. 2016;196(6):1670–1675.
   PubMed Web of Science ®Google Scholar
• Costello AJ, Bowsher WG, Bolton DM, et al. Laser ablation of the prostate in patients with benign prostatic hypertrophy. Br J Urol. 1992;69(6):603–608.
   PubMedGoogle Scholar
• Patelli G, Ranieri A, Paganelli A, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Cardiovasc Intervent Radiol. 2017;40(9):1440–1446.
   PubMed Web of Science ®Google Scholar
• van Kollenburg RAA, van Riel L, Bloemen PR, et al. Transperineal laser ablation treatment for lower urinary tract symptoms due to benign prostatic obstruction: protocol for a prospective in vivo pilot study. JMIR Res Protoc. 2020;9(1):e15687.
   PubMed Web of Science ®Google Scholar
• Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–479.
   PubMed Web of Science ®Google Scholar
• Lepor H. Pathophysiology of benign prostatic hyperplasia in the aging male population. Reviews in Urology. 2005;7 (Suppl 4):S3–S12.
   Google Scholar
• Pacella CM, Patelli G, Iapicca G, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Prostate Cancer Prostatic Dis. 2020;23(2):356–363.
   PubMed Web of Science ®Google Scholar
• Vogl TJ, Naguib NN, Eichler K, et al. Volumetric evaluation of liver metastases after thermal ablation: long-term results following MR-guided laser-induced thermotherapy. Radiology. 2008;249(3):865–871.
   PubMed Web of Science ®Google Scholar
• Sequeiros RB, Kariniemi J, Ojala R, et al. Liver tumor laser ablation - increase in the subacute ablation lesion volume detected with post procedural MRI. Acta Radiol. 2010;51(5):505–511.
   PubMed Web of Science ®Google Scholar
• Tay KJ, Cheng CWS, Lau WKO, et al. Focal therapy for prostate cancer with in-bore MR-guided focused ultrasound: two-year follow-up of a phase I trial-complications and functional outcomes. Radiology. 2017;285(2):620–628.
   PubMed Web of Science ®Google Scholar
• Atri M, Gertner MR, Haider MA, et al. Contrast-enhanced ultrasonography for real-time monitoring of interstitial laser thermal therapy in the focal treatment of prostate cancer. Can Urol Assoc J. 2009;3(2):125–130.
   PubMed Web of Science ®Google Scholar
• Cheng HL, Haider MA, Dill-Macky MJ, et al. MRI and contrast-enhanced ultrasound monitoring of prostate microwave focal thermal therapy: an in vivo canine study. J Magn Reson Imaging. 2008;28(1):136–143.
   PubMed Web of Science ®Google Scholar
• Liu R, Duan S, Cao H, et al. A pilot study of the shapes of ablation lesions in the canine prostate by laser, radiofrequency and microwave and their clinical significance. PLoS One. 2020;15(4):e0223229.
   PubMed Web of Science ®Google Scholar
• Onik GM, Cohen JK, Reyes GD, et al. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer. 1993;72(4):1291–1299.
   PubMed Web of Science ®Google Scholar
• Feng C, Hu B, Hu B, et al. Comparative study of conventional US, contrast enhanced US and enhanced MR for the follow-up of prostatic radiofrequency ablation. Exp Ther Med. 2017;13(6):3535–3542.
   PubMed Web of Science ®Google Scholar
• Liu JB, Merton DA, Wansaicheong G, et al. Contrast enhanced ultrasound for radio frequency ablation of canine prostates: initial results. J Urol. 2006;176(4 Pt 1):1654–1660.
   PubMed Web of Science ®Google Scholar
• Stafford RJ, Shetty A, Elliott AM, et al. Magnetic resonance guided, focal laser induced interstitial thermal therapy in a canine prostate model. J Urol. 2010;184(4):1514–1520.
   PubMed Web of Science ®Google Scholar
• Di Matteo F, Martino M, Rea R, et al. EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointest Endosc. 2010;72(2):358–363.
   PubMed Web of Science ®Google Scholar
• Bulvik BE, Rozenblum N, Gourevich S, et al. Irreversible electroporation versus radiofrequency ablation: a comparison of local and systemic effects in a small-animal model. Radiology. 2016;280(2):413–424.
   PubMed Web of Science ®Google Scholar
• Jacobsen SJ, Jacobson DJ, Girman CJ, et al. Natural history of prostatism: risk factors for acute urinary retention. J Urol. 1997;158(2):481–487.
   PubMed Web of Science ®Google Scholar
• Vesely S, Knutson T, Damber JE, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. Scand J Urol Nephrol. 2003;37(4):322–328.
   PubMed Web of Science ®Google Scholar
• Kang MY, Ku JH, Oh SJ. Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms. J Korean Med Sci. 2010;25(2):272–275.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Brace CL, Lee FT, et al. Principles of and advances in percutaneous ablation. Radiology. 2011;258(2):351–369.
   PubMed Web of Science ®Google Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer. 2014;14(3):199–208.
   PubMed Web of Science ®Google Scholar
• Nikfarjam M, Muralidharan V, Malcontenti-Wilson C, et al. Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy. Lasers Surg. Med. 2005;37(1):64–73.
   PubMed Web of Science ®Google Scholar
• Peters RD, Chan E, Trachtenberg J, et al. Magnetic resonance thermometry for predicting thermal damage: an application of interstitial laser coagulation in an in vivo canine prostate model. Magn. Reson. Med. 2000;44(6):873–883.
   PubMed Web of Science ®Google Scholar
• Cowan DF, Orihuela E, Motamedi M, et al. Histopathologic effects of laser radiation on the human prostate. Modern pathology: an official journal of the United States and Canadian Academy of. Pathology, Inc. 1995;8:716–721.
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Kratzik C, Susani M, et al. Tissue ablation in benign prostatic hyperplasia with high intensity focused ultrasound. J Urol. 1994;152(6 Pt 1):1956–1960; discussion 60.
   PubMed Web of Science ®Google Scholar
• Zvara P, Karpman E, Stoppacher R, et al. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology. 1999;54(3):411–415.
   PubMed Web of Science ®Google Scholar
• de Wildt MJ, Debruyne FM, de la Rosette JJ. High-energy transurethral microwave thermotherapy: a thermoablative treatment for benign prostatic obstruction. Urology. 1996;48(3):416–423.
   PubMed Web of Science ®Google Scholar